The advance of CAR-T technology and the rise of immuno-oncology alongside emerging new payment models highlight the annual review in Evidence-Based Oncology™, which looks at how researchers are harnessing the immune system to bring unprecedented results in cancer care.
(PRWeb February 23, 2017)
Read the full story at http://www.prweb.com/releases/2017/02/prweb14092365.htm
For more information, please visit
http://www.prweb.com/releases/2017/02/prweb14092365.htm